IDDF2024-ABS-0270 Efficacy and safety of bulevirtide in combination with pegylated interferon alfa-2a in patients with chronic hepatitis delta: primary endpoint results from a phase 2b open-label, randomized, multicenter study MYR204

Supporters

Support the authors with ResearchCoin

Tip RSC

Topics

Medicine

Epidemiology

Internal Medicine

Gastroenterology

Virology

Show all topics

DOI

10.1136/gutjnl-2024-iddf.195